United Therapeutics Quarterly Balance Sheet
NASDAQ: UTHRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
United Therapeutics financial position
As of Jun 30, 2026, United Therapeutics reported total assets of $7.22 billion, down 8.7% from a year earlier against total liabilities of $819.8 million. Shareholders' equity stood at $6.40 billion, or 88.6% of assets. The company held $1.80 billion in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.73, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
United Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.80B | 1.28B | 1.56B | 1.34B | 1.59B | 1.90B | 1.70B | 1.55B | 1.36B | 1.25B | 1.21B | 1.11B |
| Short-Term Investments | 859.10M | 874.00M | 1.36B | 1.43B | 1.46B | 1.42B | 1.57B | 1.77B | 1.62B | 1.46B | 1.79B | 1.77B |
| Receivables | 310.30M | 312.00M | 350.20M | 297.70M | 379.30M | 322.00M | 279.30M | 341.80M | 290.70M | 307.30M | 278.90M | 258.60M |
| Inventory | 193.80M | 178.30M | 183.10M | 176.50M | 169.20M | 165.40M | 157.90M | 146.70M | 136.50M | 120.20M | 111.80M | 104.30M |
| Total Current Assets | 3.48B | 2.87B | 3.70B | 3.49B | 3.83B | 3.94B | 3.87B | 4.00B | 3.62B | 3.25B | 3.55B | 3.46B |
| Property, Plant & Equipment | 1.93B | 1.84B | 1.73B | 1.56B | 1.36B | 1.30B | 1.22B | 1.16B | 1.09B | 1.07B | 1.05B | 992.20M |
| Goodwill | — | — | 32.30M | — | — | — | 32.30M | — | — | — | 33.70M | — |
| Long-Term Investments | 1.14B | 1.32B | 1.78B | 1.57B | 1.92B | 1.71B | 1.48B | 1.28B | 1.33B | 1.49B | 1.91B | 2.06B |
| Total Assets | 7.22B | 6.71B | 7.88B | 7.35B | 7.91B | 7.74B | 7.36B | 7.12B | 6.72B | 6.50B | 7.17B | 7.02B |
| Accounts Payable | 497.80M | 498.30M | 7.10M | 468.00M | 432.00M | 367.00M | 6.00M | 363.90M | 325.30M | 305.10M | 5.60M | 333.40M |
| Total Current Liabilities | 607.80M | 599.10M | 560.60M | 546.30M | 527.10M | 721.50M | 738.10M | 873.40M | 832.30M | 860.60M | 804.40M | 744.10M |
| Total Liabilities | 819.80M | 813.10M | 783.80M | 760.90M | 734.40M | 936.70M | 920.00M | 1.02B | 1.03B | 1.16B | 1.18B | 1.31B |
| Shareholders' Equity | 6.40B | 5.90B | 7.10B | 6.59B | 7.17B | 6.81B | 6.44B | 6.10B | 5.70B | 5.34B | 5.98B | 5.71B |
| Retained Earnings | 9.16B | 8.83B | 8.56B | 8.19B | 7.85B | 7.54B | 7.22B | 6.92B | 6.61B | 6.33B | 6.03B | 5.81B |
| Net Cash (Debt) | 2.66B | 2.15B | 2.92B | 2.77B | 3.05B | 3.32B | 3.27B | 3.33B | 2.97B | 2.71B | 2.99B | 2.88B |
| Shares Outstanding | 42.68M | 42.16M | 43.64M | 42.90M | 45.22M | 45.07M | 44.83M | 44.62M | 44.42M | 44.20M | 47.04M | 46.98M |
This table shows 12 quarterly periods of United Therapeutics's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow UTHR's reporting calendar. What is a balance sheet?